- Moderna Inc MRNA has announced a new agreement to supply 25 million doses of its COVID-19 vaccine to Australia.
- The deal includes 10 million doses of the company's mRNA-1273 vaccine delivered this year and 15 million doses of its variant booster vaccine candidate to be delivered in 2022.
- The agreement is subject to the approval of mRNA-1273 and the booster vaccine candidate by Australia's Therapeutic Goods Administration.
- Price Action: MRNA shares are down 0.75% at $157.84 during the premarket session on the last check Wednesday.
Loading...
Loading...
MRNAModerna Inc
$28.413.46%
Edge Rankings
Momentum
5.42
Growth
Not Available
Quality
Not Available
Value
68.61
Price Trend
Short
Medium
Long
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
